Veterinary Medicines

Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs

Authorised
  • Sodium glycerophosphate pentahydrate
  • Magnesium chloride hexahydrate
  • CALCIUM GLUCONATE FOR INJECTION
Download as PDF

Identifikacija proizvoda

Naziv VMP-a:
Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs
Kaltetan forte 458,4 mg/1 ml + 125 mg/1 ml + 20 mg/ml Roztwór do infuzji
Djelatna tvar:
Ciljne vrste životinja:
Način primjene:
  • Intravenski

Pojedinosti o proizvodu

Djelatna tvar i jačina:
  • Dostupno samo u English
    20.00
    miligram
    /
    1.00
    mililitar
  • Dostupno samo u English
    125.00
    miligram
    /
    1.00
    mililitar
  • Dostupno samo u English
    458.40
    miligram
    /
    1.00
    mililitar
Farmaceutski oblik:
  • Otopina za infuziju
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Milk
        5
        week
    • Cattle
      • Meat and offal
        5
        week
    • Pig
      • Meat and offal
        5
        week
Kod anatomsko-terapijsko-kemijske klasifikacije (ATKvet kȏd):
  • QA12AX
Pravni status opskrbe:
Status odobrenja:
  • Važeće
Authorised in:
  • Poland
Available in:
  • Poland
Opis paketa:

Dodatne informacije

Entitlement type:
Pravna osnova za odobrenje proizvoda:
Nositelj odobrenja za stavljanje u promet:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Mjesta proizvodnje za izdavanje serije:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Odgovorno tijelo:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Broj autorizacije:
  • 3172
Datum promjene statusa odobrenja:
Referentna država članica:
Broj postupka:
  • PL/V/0110/002
Dotična država članica:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."